This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Arqule, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Takanori Yasukochi: Innovator in Pharmaceutical Compositions
Introduction: Takanori Yasukochi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, with a focus on compounds that have the potential to treat cell proliferative disorders, including cancer.
Latest Patents: Yasukochi holds a patent for "Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same." This invention pertains to the synthesis of pyrroloquinolinyl-pyrrolidine-2,5-dione compounds and their use in pharmaceutical formulations intended for treating various conditions related to cell proliferation, like cancer.
Career Highlights: Yasukochi is currently employed at Arqule, Inc., where he continues to explore innovations in drug discovery and development. His work is critical in the ongoing fight against diseases that affect cellular growth and replication.
Collaborations: Throughout his career, Yasukochi has collaborated with distinguished colleagues such as Mark Anthony Ashwell and Darin Kizer. These partnerships reflect a commitment to advancing the scientific community's understanding of complex medical challenges and crafting effective solutions.
Conclusion: Takanori Yasukochi exemplifies innovation in the pharmaceutical industry through his patented work and collaborative spirit. His inventions hold the promise of contributing to effective treatments for serious health conditions, underscoring the importance of continued research and development in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile